Senate Republicans Report Wasteful Spending in Government
A recent report by Senate Republicans highlights significant waste of federal funds last year. This includes expenses related to transgender animal experiments in China, tests on beagles, and halted fetal tissue research.
In his ninth annual report, “Federal Failures,” Senator James Lankford (R-Okla.) detailed examples of government mismanagement and offered suggestions to improve efficiency moving forward. He remarked that since the start of President Trump’s second term, the Republican-controlled Congress has aimed to save taxpayer money and redefine spending in Washington. But, as he emphasized, “the work is not done yet.”
Lankford pointed out that the federal government often becomes bogged down in inefficiency, and it’s essential to cut through the red tape. He believes that more needs to be done for the betterment of taxpayers.
Some of the most concerning examples of wasted funds include various National Institutes of Health (NIH) grant programs from the Biden administration. Among these was approximately $240 million dedicated to studies testing hormones and surgical procedures on animals to model transgender individuals, which the Trump administration later terminated.
In 2024, the NIH also awarded $53 million in grants for research involving human fetal tissue obtained from elective abortions. Last year, it came to light that 17 of these grants remained active. Following scrutiny from advocacy groups, NIH did eventually end the funding, but concerns linger about what could happen if a future administration decides to revive or expand such research, which Lankford describes as both unethical and scientifically behind the times.
Lankford also found that $124,000 of taxpayer money was allocated to drug research in China, which involved experimenting on as many as 300 beagles weekly. Despite the NIH’s decision not to renew the contract after public outcry, the situation remains troubling, as China holds several animal research labs with connections to its government. These labs still have NIH approval for U.S. funding.
